Skip to search formSkip to main contentSkip to account menu

Neoral

National Institutes of Health

Related topics

Related topics

3 relations

Broader (1)

Cyclosporine
Cyclosporine Oral Solution [Neoral]cyclosporine, modified 25 MG Oral Capsule [Neoral]

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2004
Highly Cited
2004
Influence of a Fat-Rich Meal on the Pharmacokinetics of a New Oral Formulation of Cyclosporine in a Crossover Comparison with the Market Formulation
The influence of a fat-rich meal on the pharmacokinetics of cyclosporine from a new oral formulation (Sandimmune Neoral) was… 
Highly Cited
2003
Highly Cited
2003
Long-term graft survival with neoral and tacrolimus: a paired kidney analysis.
Calcineurin inhibitors (CNI) are an important component of most immunosuppressive protocols utilized in renal transplantation… 
Highly Cited
2002
Highly Cited
2002
Cyclosporine Microemulsion (Neoral®) Absorption Profiling and Sparse‐sample Predictors During the First 3 Months after Renal Transplantation
Recent data suggest that optimal cyclosporine (CsA) exposure early post‐transplant significantly reduces the risk of acute graft… 
2001
2001
Single-center experience with tacrolimus versus cyclosporine-Neoral in renal transplant recipients
Abstract. Tacrolimus has proven to be superior to cyclosporine-Sandimmune with regard to the prevention of acute rejections, but… 
2000
2000
Conversion to neoral for neurotoxicity after primary adult liver transplantation under tacrolimus.
BACKGROUND Neurological complications after orthotopic liver transplantation (OLTX) have remained a major concern in a small… 
Highly Cited
1999
Highly Cited
1999
Suppression of acute rejection in allogeneic rat lung transplantation: a study of the efficacy and pharmacokinetics of rapamycin derivative (SDZ RAD) used alone and in combination with a…
1999
1999
Randomized, trough blood cyclosporine concentration-controlled trial to compare the pharmacodynamics of Sandimmune and Neoral in de novo lung transplant recipients.
The greater and more consistent absorption of cyclosporine from the microemulsion formulation (Neoral; Novartis Pharmaceuticals… 
Highly Cited
1998
Highly Cited
1998
Comparison of neoral dose monitoring with cyclosporine through levels versus 2-hr postdose levels in stable liver transplant patients.
BACKGROUND We reported that cyclosporine 2-hr postdose levels (C2) correlate better with the AUC0-4 hr than trough levels (C0) in… 
Review
1997
Review
1997
Bioavailability and pharmacokinetics of cyclosporine formulations: Neoral® vs Sandimmune®
This review will examine the pharmacokitietics of cyclosporine, which is the active ingredietit in two formulatiotis: Neoral® and… 
1997
1997
Pharmacokinetics of cyclosporine in pediatric long-term liver transplant recipients converted from Sandimmun to Neoral
Abstract Absorption of cyclosporin from the microemulsion formulation Neoral is less variable than from Sandimmun. Because of a… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)